An anti-SS-B result of 0.2 falls well below the positive cutoff on virtually every commercial assay used today, meaning the test did not detect meaningful levels of anti-SS-B (also called anti-La) antibodies in your blood. Whether labs report results in antibody index units, arbitrary units per milliliter, or a simple ratio, the threshold for a positive result is typically set at 1.0 or higher, and 0.2 sits firmly in negative territory. That said, a negative anti-SS-B result does not rule out Sjögren’s syndrome or other autoimmune conditions, because this particular antibody is only one piece of a much larger diagnostic picture.
What Anti-SS-B Actually Measures
The “SS-B” in your lab report refers to a protein more formally known as La, a molecule that lives inside the nucleus of your cells. La/SS-B is an RNA-binding protein involved in processing certain small RNA molecules that the cell uses for normal housekeeping functions.1PubMed Central. Developmental characterization of a Drosophila RNA-binding protein homologous to the human systemic lupus erythematosus-associated La/SS-B autoantigen More recent research has shown it also helps stabilize precursors of microRNAs, tiny regulatory molecules that fine-tune gene activity throughout the body.2Journal of Biological Chemistry. Autoantigen La/SSB promotes the biogenesis of small noncoding RNAs by acting as a pre-miRNA-binding protein
In autoimmune diseases like Sjögren’s syndrome and lupus, the immune system mistakenly targets this protein and produces antibodies against it. When a lab runs an anti-SS-B test, it is checking whether those antibodies are circulating in your blood. A result of 0.2 means the level detected was negligible, either absent entirely or present in a trace amount far too low to be considered clinically significant.
How to Read the Number on Your Report
Lab reports for anti-SS-B can look confusing because different testing platforms use different scales. Some report results as an antibody index where below 1.0 is negative, 1.0 to 1.4 is equivocal, and above 1.5 is positive. Others use units per milliliter with their own cutoff thresholds. The key thing to look for on your report is the reference range printed next to the result. Your 0.2 will almost certainly fall in the “negative” or “not detected” zone regardless of which scale your lab uses.
One wrinkle worth knowing: the testing method itself can influence what gets flagged. Studies comparing different assay platforms have found that agreement between methods is generally strong for anti-SS-B, with one evaluation reporting roughly 99% agreement and 89% sensitivity when a newer bead-based system was matched against traditional methods.3PubMed Central. Evaluation of multiplexed fluorescent microsphere immunoassay for detection of autoantibodies to nuclear antigens But occasional discordant results do happen. In one study evaluating a large cohort, a handful of patients tested positive for anti-SS-B on one platform while testing negative on another.4Arthritis & Rheumatology. Does Multiplex Flow Immunoassay Underdetect SSA and SSB Antibodies? An Evaluation of the Sjogren’s International Collaborative Clinical Alliance (SICCA) Cohort These discrepancies were small in number and often involved weak or borderline reactivity, not clear-cut positive results. A reading of 0.2, sitting far from any borderline zone, is unlikely to be a platform artifact.
Why SS-B Almost Never Shows Up Alone
If your doctor ordered anti-SS-B, they almost certainly ordered anti-SS-A (also called anti-Ro) at the same time. These two antibodies are closely linked. Anti-SS-B is far more common as a companion to anti-SS-A than as a solo finding. In a large survey of over 1,100 sera that tested positive for one or both antibodies, only about 14% had anti-SS-B without anti-SS-A, while about a third had both together.5PLoS ONE. Isolated positive anti-SS-B autoantibodies are not related to clinical features of systemic autoimmune diseases: Results from a routine population survey
A separate study examining over 80,000 anti-SS-B test requests found that among the patients who initially appeared to have isolated anti-SS-B positivity, many of those results did not hold up when confirmed by a different testing method. After confirmatory testing, the rate of truly isolated anti-SS-B dropped to under 4% of all anti-SS-B-positive patients.6PubMed Central. Isolated anti-SS-B (La) antibodies: rare occurrence and lack of diagnostic value The researchers concluded that isolated anti-SS-B positivity is rare and has limited diagnostic value on its own.
This matters for you because it means anti-SS-B was never the antibody carrying the diagnostic weight in the first place. If both your anti-SS-A and anti-SS-B came back negative, the antibody part of the Sjögren’s workup is negative. If your anti-SS-A came back positive but your anti-SS-B was 0.2, the positive anti-SS-A is the finding your doctor will focus on.
What This Means for a Sjögren’s Diagnosis
Sjögren’s syndrome is diagnosed using a points-based system established by the American College of Rheumatology and the European Alliance of Associations for Rheumatology. To meet the classification criteria, you need a total score of at least 4 from five possible items. Anti-SS-A positivity and a positive lip biopsy each count for 3 points. Three other tests, measuring tear production, eye surface damage, and unstimulated saliva flow, each contribute 1 point.7PubMed Central. 2016 ACR-EULAR Classification Criteria for primary Sjögren’s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts
Notice something conspicuously absent from that list: anti-SS-B. The current classification criteria do not include anti-SS-B at all. A positive anti-SS-B result does not add points toward a Sjögren’s diagnosis, and a negative one does not subtract them. Anti-SS-A is the serological marker that matters in the scoring system. Your negative anti-SS-B of 0.2, by itself, has no direct impact on whether you meet or miss the diagnostic threshold.
So why do labs still test for it? Partly because anti-SS-B was included in older diagnostic criteria and the test panel has not been universally updated. Partly because a positive anti-SS-B alongside a positive anti-SS-A can provide additional clinical context, particularly around pregnancy risk and certain disease patterns. And partly because some clinicians still find it useful for characterizing the type of immune response, even if it no longer formally contributes to the classification score.
When Anti-SS-B Is Positive but Anti-SS-A Is Not
A small number of patients do test positive for anti-SS-B without a corresponding positive anti-SS-A. Research suggests this antibody profile does not behave the same way as the more typical double-positive pattern. In one analysis, patients with anti-SS-B alone looked clinically similar to patients who were negative for both antibodies. They did not show the hallmark features of Sjögren’s, including reduced tear production, lower salivary flow, or the degree of glandular inflammation seen in anti-SS-A-positive patients.8PubMed Central. The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjögren’s syndrome
A large multicenter study added some nuance. Among 279 patients carrying isolated anti-SS-B, systemic disease activity was present but overwhelmingly mild. Even in the areas where these patients had the highest rates of organ involvement, the severity was lower than in patients who were positive for both antibodies.9Clinical and Experimental Rheumatology. Systemic phenotype related to primary Sjogren’s syndrome in 279 patients carrying isolated anti-La/SSB antibodies The takeaway is that isolated anti-SS-B positivity, when it does occur, does not carry the same clinical significance as anti-SS-A positivity or the double-positive pattern. Since your result is 0.2 and negative, this scenario does not apply to you, but it helps illustrate why anti-SS-B has been sidelined from the formal diagnostic criteria.
Can You Still Have Sjögren’s with All-Negative Antibodies?
Yes. The term “seronegative Sjögren’s” refers to patients who meet the clinical criteria for the disease without positive anti-SS-A or anti-SS-B antibodies. This is not a rare footnote. A meaningful fraction of people with biopsy-confirmed Sjögren’s have negative blood tests for both antibodies. In one reported case, a patient had negative results for anti-SS-A, anti-SS-B, antinuclear antibodies, and rheumatoid factor, yet her lip biopsy showed the dense lymphocyte infiltration characteristic of Sjögren’s, and she met the formal classification criteria on the strength of biopsy plus functional tests.10PubMed Central. Treatment of serologically negative Sjögren’s syndrome with tacrolimus: A case report
The labial salivary gland biopsy, where a small piece of tissue is taken from inside the lower lip and examined under a microscope, plays a particularly important role when antibodies are absent. The biopsy carries a high sensitivity and specificity for Sjögren’s and is especially useful for patients with gland dysfunction and negative antibody results.11PubMed Central. Clinical characteristics and biopsy accuracy in suspected cases of Sjögren’s syndrome referred to labial salivary gland biopsy Clinicians investigating seronegative sicca (dry eyes and dry mouth without positive antibodies) will often rely on this procedure to confirm or rule out the diagnosis.12Bulletin of the National Research Centre. Labial salivary gland biopsy: a crucial method for confirming seronegative Sjogren’s syndrome—a case report Even in younger patients, negative serology should not be treated as an absolute reason to stop investigating if the clinical picture is suspicious.13Rheumatology Advances in Practice. Primary Sjogren’s Syndrome (pSS) in a seronegative adolescent female with family history of Behçet’s disease: A challenging disease to diagnose Case-based discussion
If your doctor suspects Sjögren’s despite a negative anti-SS-B and a negative anti-SS-A, the workup does not end with the blood tests. They may proceed to functional assessments of your tears and saliva, and possibly a lip biopsy.
The Other Tests That Matter More
Because a 0.2 anti-SS-B result has essentially no diagnostic weight on its own, it is worth understanding the tests that do matter for Sjögren’s evaluation. The Schirmer test measures tear production by placing a small strip of filter paper under the lower eyelid for five minutes. A result of 5 millimeters or less of wetting is considered abnormal and counts toward the classification criteria. Unstimulated salivary flow rate is measured by having you spit into a container over a set period without stimulation; a flow rate at or below 0.1 milliliter per minute is the current threshold, though some researchers have suggested raising it to 0.2 milliliter per minute to improve screening accuracy.14PubMed Central. Unstimulated whole saliva flow for diagnosis of primary Sjögren’s syndrome: time to revisit the threshold? Ocular staining scores assess damage to the surface of the eye using special dyes.
Newer research is also exploring salivary biomarkers that could complement or eventually replace some of these tests. One diagnostic model combined salivary proteins with serum antibodies and the Schirmer test and achieved strong accuracy in distinguishing Sjögren’s patients from controls.15PubMed Central. A non-invasive model for diagnosis of primary Sjogren’s disease based on salivary biomarkers, serum autoantibodies, and Schirmer’s test Meanwhile, researchers have identified novel autoantibodies that may pick up cases currently missed by standard SS-A/SS-B testing. In one study, these novel antigens identified over half of Sjögren’s patients who lacked the standard anti-Ro/SS-A marker, with perfect specificity.16Annals of the Rheumatic Diseases. Autoantibodies identify primary Sjögren’s syndrome in patients lacking serum IgG specific for Ro/SS-A and La/SS-B These approaches are still in research stages, but they signal that the antibody landscape for Sjögren’s diagnosis is likely to expand beyond SS-A and SS-B in coming years.
Should You Get Retested?
A result of 0.2 is not borderline. It is solidly negative, and repeating the same test without a good clinical reason is unlikely to change the outcome. A retrospective audit of repeat extractable nuclear antigen testing found that results rarely change on retesting, and a new diagnosis prompted by a changed result was uncommon. The researchers concluded that repeat testing is only warranted if your symptoms or clinical presentation have meaningfully changed since the first test was run.17Rheumatology. Utility of repeat extractable nuclear antigen antibody testing: a retrospective audit
If you develop new symptoms, particularly worsening dryness, unexplained joint pain, swollen salivary glands, or signs of systemic autoimmune disease, your doctor might reasonably reorder the panel. But the goal at that point is reassessing the full clinical picture, not just rechecking a number that was far from positive.
Pregnancy and Anti-SS-B Antibodies
One context where anti-SS-B does carry independent clinical weight is pregnancy planning. Anti-SS-B (anti-La) antibodies, along with anti-SS-A (anti-Ro), can cross the placenta and in rare cases cause a condition called autoimmune congenital heart block in the developing baby. This occurs in roughly 2% of pregnancies exposed to anti-Ro/SS-A antibodies, with the recurrence rate in subsequent pregnancies being about nine times higher.18PubMed Central. Autoimmune Congenital Heart Block: A Review of Biomarkers and Management of Pregnancy
Because this risk is driven primarily by anti-SS-A, a negative anti-SS-B at 0.2 in someone who also tests negative for anti-SS-A is reassuring in this context. The antibodies are not present at levels that would cross the placenta and cause harm. If anti-SS-A is positive but anti-SS-B is negative, the risk is determined by the anti-SS-A status, and your obstetrician or rheumatologist will guide monitoring based on that result.
Peripheral Neuropathy and Sjögren’s Beyond Dryness
One reason doctors sometimes order SS-A/SS-B panels in people who do not have obvious dry eyes or dry mouth is that Sjögren’s syndrome can present with symptoms that have nothing to do with moisture. One of the more common extraglandular manifestations is peripheral neuropathy, which affects the nerves outside the brain and spinal cord. A meta-analysis pooling data from 29 studies involving nearly 5,000 Sjögren’s patients found that about 15% had large-fiber peripheral neuropathy.19PubMed Central. Primary Sjögren syndrome‐related peripheral neuropathy: A systematic review and meta‐analysis Symptoms can include numbness, tingling, burning sensations, or weakness in the hands and feet.
If your antibody panel was ordered because of unexplained neuropathy rather than dryness, a negative anti-SS-B of 0.2 is still just one data point. The evaluation for Sjögren’s-related neuropathy follows the same pathway: checking anti-SS-A, assessing for sicca symptoms you might have overlooked or attributed to something else, and potentially pursuing a lip biopsy if suspicion remains high. Neuropathy can be the presenting feature of Sjögren’s well before dryness becomes noticeable, so a thorough workup matters even when the antibody panel is unremarkable.